Drug Database
Back to search

Netherlands· NL-c65ad58e6472

mRESVIA dispersie voor injectie in een voorgevulde spuit mRNA-vaccin tegen het respiratoir syncytieel virus

A respiratorisches-synzytial-virus impfstoffe product containing respiratoir syncytieel virus (rsv) f glycoproteine gestabiliseerd in de prefusie conformatie, registered in Netherlands by Moderna Biotech Spain S.L.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BX05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedmRESVIA dispersie voor injectie in ee…ATCJ07BX05REGISTER NO.NL-c65ad58e6472PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about respiratoir syncytieel virus (rsv) f glycoproteine gestabiliseerd in de prefusie conformatieAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search respiratorisches-synzytial-virus impfstoffe products by name

Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
RESPIRATOIR SYNCYTIEEL VIRUS (RSV) F GLYCOPROTEINE GESTABILISEERD IN DE PREFUSIE CONFORMATIE
Manufacturer
Moderna Biotech Spain S.L.
Country
Netherlands (NL)
ATC code
J07BX05
ATC class
Respiratorisches-Synzytial-Virus Impfstoffe
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1849

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Respiratorisches-synzytial-virus impfstoffe in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All respiratorisches-synzytial-virus impfstoffe products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/447ef1fb-3091-409e-8016-7670dc424222
GET /v1/drugs/447ef1fb-3091-409e-8016-7670dc424222?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/mresvia-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Respiratory Syncytial Virus Vaccines",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131846",
  "excipients": [
    "1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLEENGLYCOL-2000",
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "CHOLESTEROL",
    "COLFOSCERILSTEARAAT",
    "HEPTADECAAN-9-YL 8-((2-HYDROXYETHYL)(6-OXO-6-(UNDECYLOXY) HEXYL) AMINO) OCTANOAAT",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "SACCHAROSE",
    "TROMETAMOL",
    "TROMETAMOLHYDROCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "RESPIRATOIR SYNCYTIEEL VIRUS (RSV) F GLYCOPROTEINE GESTABILISEERD IN DE PREFUSIE CONFORMATIE"
  ],
  "leaflet_url": null,
  "authorised_at": "2024/08/22",
  "procedure_number": "EMEA/H/C/006278",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1849",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about respiratorisches-synzytial-virus impfstoffe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console